Lineweaver Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,977
Closed -$1.4M 142
2022
Q4
$1.4M Sell
28,977
-1,053
-4% -$46.2K 0.43% 49
2022
Q3
$1.14M Buy
30,030
+5,422
+22% +$242K 0.37% 55
2022
Q2
$1.23M Buy
+24,608
New +$1.31M 0.41% 49

Other funds holding SNY

Lineweaver Wealth Advisors's SNY Position: Q1 2023 in Review

Lineweaver Wealth Advisors sold out of Sanofi (SNY) in Q1 2023, closing a stake of 28,977 shares — an estimated $1.4M sold.

Lineweaver Wealth Advisors first reported a position in SNY in Q2 2022 and held it in 3 quarters. The position peaked at $1.4M in Q4 2022. 678 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

  • Lineweaver Wealth Advisors reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
  • Lineweaver Wealth Advisors sold 28,977 Sanofi shares in Q1 2023, an estimated $1.4M.
  • Lineweaver Wealth Advisors first reported a position in Sanofi in Q2 2022 and held it in 3 quarters.
  • Lineweaver Wealth Advisors's Sanofi position peaked at $1.4M in Q4 2022.
  • 678 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on Lineweaver Wealth Advisors's 13F filing for Q1 2023, filed 2 May 2023.